Novavax Inc (NVAX)
14.38
+1.48
(+11.43%)
USD |
NASDAQ |
May 16, 16:00
14.43
+0.06
(+0.38%)
After-Hours: 16:29
Novavax Cash from Operations (Quarterly): -83.56M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -83.56M |
December 31, 2023 | -176.78M |
September 30, 2023 | -39.66M |
June 30, 2023 | -171.94M |
March 31, 2023 | -325.59M |
December 31, 2022 | -117.82M |
September 30, 2022 | -38.71M |
June 30, 2022 | -170.90M |
March 31, 2022 | -88.51M |
December 31, 2021 | -342.41M |
September 30, 2021 | -142.14M |
June 30, 2021 | 144.41M |
March 31, 2021 | 663.08M |
December 31, 2020 | -128.57M |
September 30, 2020 | -6.497M |
June 30, 2020 | 115.63M |
March 31, 2020 | -23.11M |
December 31, 2019 | -23.74M |
September 30, 2019 | -32.26M |
June 30, 2019 | -30.01M |
March 31, 2019 | -50.61M |
December 31, 2018 | -45.27M |
September 30, 2018 | -33.51M |
June 30, 2018 | -39.97M |
March 31, 2018 | -66.08M |
Date | Value |
---|---|
December 31, 2017 | -43.40M |
September 30, 2017 | -44.18M |
June 30, 2017 | -12.40M |
March 31, 2017 | -44.50M |
December 31, 2016 | -64.55M |
September 30, 2016 | -62.36M |
June 30, 2016 | -62.03M |
March 31, 2016 | -69.83M |
December 31, 2015 | -54.75M |
September 30, 2015 | -28.53M |
June 30, 2015 | -12.32M |
March 31, 2015 | -30.49M |
December 31, 2014 | -19.77M |
September 30, 2014 | -15.87M |
June 30, 2014 | -10.94M |
March 31, 2014 | -20.43M |
December 31, 2013 | -12.26M |
September 30, 2013 | -14.88M |
June 30, 2013 | -7.633M |
March 31, 2013 | -10.58M |
December 31, 2012 | -3.252M |
September 30, 2012 | -4.631M |
June 30, 2012 | -6.126M |
March 31, 2012 | -4.22M |
December 31, 2011 | -2.869M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-342.41M
Minimum
Dec 2021
663.08M
Maximum
Mar 2021
-50.95M
Average
-61.60M
Median
Cash from Operations (Quarterly) Benchmarks
Pfizer Inc | 1.09B |
Moderna Inc | -989.00M |
Sensus Healthcare Inc | -8.187M |
Agilent Technologies Inc | 485.00M |
BioCryst Pharmaceuticals Inc | -53.68M |
Cash from Operations (Quarterly) Related Metrics
Cash from Investing (Quarterly) | -7.25M |
Cash from Financing (Quarterly) | 5.886M |
Free Cash Flow | -514.43M |
Free Cash Flow Per Share (Quarterly) | -0.649 |
Free Cash Flow to Equity (Quarterly) | -91.22M |
Free Cash Flow to Firm (Quarterly) | -86.63M |
Free Cash Flow Yield | -30.37% |